Essential Partners’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25.7K Buy
270
+18
+7% +$1.62K 0.01% 829
2026
Q2
$20.5K Buy
252
+12
+5% +$950 0.01% 894
2026
Q1
$17.5K Sell
240
-237
-50% -$18.5K 0.01% 981
2025
Q4
$36.5K Sell
477
-424
-47% -$32K 0.01% 695
2025
Q3
$69.5K Buy
901
+799
+783% +$66.7K 0.02% 522
2025
Q2
$8.58K Buy
+102
New +$8.93K ﹤0.01% 888

Other funds holding IOSP

Essential Partners's IOSP Position: Q3 2026 in Review

Essential Partners increased its Innospec (IOSP) stake by 7.1% in Q3 2026, buying an estimated $1.62K and bringing the position to 270 shares worth $25.7K. The position accounts for 0.01% of the portfolio, ranked #829.

Essential Partners first reported a position in IOSP in Q2 2025 and has held it in 6 quarters since. The position peaked at $69.5K in Q3 2025. 16 funds tracked by Wall St. Rank hold IOSP as of Q3 2026.

  • Essential Partners held 270 shares of Innospec worth $25.7K as of Q3 2026.
  • Essential Partners bought 18 Innospec shares in Q3 2026, an estimated $1.62K.
  • Innospec made up 0.01% of Essential Partners's portfolio in Q3 2026, its #829 holding.
  • Essential Partners first reported a position in Innospec in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's Innospec position peaked at $69.5K in Q3 2025.
  • 16 funds tracked by Wall St. Rank held Innospec as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.